Cooper-DeHoff, Rhonda M <br/><br/>
Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.  [electronic resource] 

 -  Hypertension (Dallas, Tex. : 1979)  Jan 2010 
 - 61-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4563 
<br/><br/><label>Standard No.: </label>10.1161/HYPERTENSIONAHA.109.139592  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antihypertensive Agents--adverse effects<br/>Atenolol--adverse effects<br/>Diabetes Mellitus--chemically induced<br/>Drug Therapy, Combination<br/>Fasting--blood<br/>Female<br/>Humans<br/>Hydrochlorothiazide--adverse effects<br/>Hyperglycemia--blood<br/>Hypertension--blood<br/>Hypertriglyceridemia--blood<br/>Hyperuricemia--chemically induced<br/>Lipoproteins, HDL--blood<br/>Male<br/>Metabolic Diseases--chemically induced<br/>Middle Aged<br/>Obesity, Abdominal--physiopathology<br/>Outcome Assessment, Health Care--statistics & numerical data<br/>Young Adult